Sign in

CIK 0001620463

  • Non-accelerated filer
  • Smaller reporting company

LeonaBio, Inc.

Sign in to watch
Ticker
LONA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
453368487
Phone
+1 425-620-8501
Business address
18706 NORTH CREEK PARKWAY, SUITE 104, BOTHELL, WA, 98011
Former names
Athira Pharma, Inc., M3 Biotechnology, Inc.
Open-market buys, last 90 days
$9,919,161,281
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$9,919,161,281. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Portman David J. +$9.9B 10% owner 1 filing
Date Insider Transaction Shares Price Value Owned after
2022-01-18 Worthington Mark General Counsel Grant or award · Stock Option (Right to Buy) +150,000 150,000
2022-01-18 MOEBIUS HANS Chief Medical Officer Grant or award · Stock Option (Right to Buy) +180,000 180,000
2022-01-18 CHURCH KEVIN Executive VP, Research Grant or award · Stock Option (Right to Buy) +100,000 100,000
2022-01-04 MILESON GLENNA Chief Financial Officer Exercise or conversion +6,305 $1.35 $9K 97,060
2022-01-04 MILESON GLENNA Chief Financial Officer Exercise or conversion · Stock Option (Right to Buy) −6,305 0
2021-11-18 Litton Mark James Chief Executive Officer Grant or award +885 $12.51 $11K 115,758
2021-11-18 MOEBIUS HANS Chief Medical Officer Grant or award +829 $12.51 $10K 31,256
2021-11-18 CHURCH KEVIN Executive VP, Research Grant or award +96 $12.51 $1K 44,414
2021-11-18 MILESON GLENNA Chief Financial Officer Grant or award +931 $12.51 $12K 90,755
2021-11-03 Worthington Mark General Counsel Grant or award · Stock Option (Right to Buy) +150,000 150,000
2021-11-03 Lenington Rachel Chief Operating Officer Grant or award · Stock Option (Right to Buy) +150,000 150,000
2021-08-17 Litton Mark James Chief Operating Officer Exercise or conversion +50,440 $1.35 $68K 114,873
2021-08-17 Litton Mark James Chief Operating Officer Exercise or conversion · Stock Option (Right to Buy) −50,440 100,880
2021-07-21 MOEBIUS HANS Chief Medical Officer Exercise or conversion +12,610 $1.35 $17K 14,665
2021-07-21 MOEBIUS HANS Chief Medical Officer Exercise or conversion +15,762 $1.35 $21K 30,427
2021-07-21 MOEBIUS HANS Chief Medical Officer Exercise or conversion · Stock Option (Right to Buy) −12,610 0
2021-07-21 MOEBIUS HANS Chief Medical Officer Exercise or conversion · Stock Option (Right to Buy) −15,762 15,763
2021-06-15 FLUKE JOHN M JR Director Other disposition −3,000 3,731
2021-06-15 FLUKE JOHN M JR Director Other acquisition +1,000 144,884
2021-06-10 MILESON GLENNA Chief Financial Officer Exercise or conversion +6,305 $1.35 $9K 89,824

Page 15 of 18 · 349 trades